Radiation Therapy to Convert the Tumor Into an In Situ Vaccine

Saved in:
Bibliographic Details
Published inInternational journal of radiation oncology, biology, physics Vol. 84; no. 4; pp. 879 - 880
Main Authors Formenti, Silvia C., MD, Demaria, Sandra, MD
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 15.11.2012
Subjects
Animals
Cell Death - immunology
Combined Modality Therapy - methods
CTLA-4 Antigen - antagonists & inhibitors
Hematology, Oncology and Palliative Medicine
Humans
Immune System - immunology
Immune Tolerance - immunology
Immunity, Cellular
Immunologic Memory
Immunotherapy - methods
Mice
Neoplasms - immunology
Neoplasms - radiotherapy
Radiation Tolerance - immunology
Radiology
T-Lymphocytes - immunology
Online AccessGet full text

Cover

Author Formenti, Silvia C., MD
Demaria, Sandra, MD
Author_xml – sequence: 1
  fullname: Formenti, Silvia C., MD
– sequence: 2
  fullname: Demaria, Sandra, MD
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23078897$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1r3DAQhkVJaTZp_0EpPvZid0aSZfsSKEs_AoFCsy29CVkeE7leaSvZgf331bJpD730NCCe9x30zBW78METY68RKgRU76bKTTH0h4oD8gpUBRyesQ22TVeKuv5xwTYgFJQiw5fsKqUJABAb-YJdcgFN23bNht18NYMziwu-2D1QNIdjsYRiG_wjxaVYHqjYrfsQi1ufn43Ps7h3y1p8N9Y6Ty_Z89HMiV49zWv27eOH3fZzeffl0-32_V1pa5RLyYceOyGIxhqHEdpa9agUCjHKnksaSbVGdIPAure15SM0sh7bthlQdoigxDV7e-49xPBrpbTovUuW5tl4CmvSyEWTa6WUGZVn1MaQUqRRH6Lbm3jUCPpkTk_6bE6fzGlQOpvLsTdPG9Z-T8Pf0B9VGbg5A5T_-ego6mQdeUuDi2QXPQT3vw3_FtjZeWfN_JOOlKawRp8datQpZ_T96Xqn4yEHaKXi4jd_PJVy
CitedBy_id crossref_primary_10_1080_2162402X_2016_1214790
crossref_primary_10_1002_1878_0261_12321
crossref_primary_10_1088_1742_6596_847_1_012054
crossref_primary_10_1016_j_ijrobp_2019_02_046
crossref_primary_10_1016_j_vaccine_2015_05_105
crossref_primary_10_1158_2326_6066_CIR_21_0119
crossref_primary_10_1186_bcr3493
crossref_primary_10_1016_S1470_2045_12_70592_2
crossref_primary_10_1016_j_biomaterials_2020_120421
crossref_primary_10_1158_1078_0432_CCR_21_3750
crossref_primary_10_1016_j_ijrobp_2018_11_019
crossref_primary_10_1016_j_ijrobp_2019_05_025
crossref_primary_10_1155_2013_658126
crossref_primary_10_1016_j_brachy_2017_06_012
crossref_primary_10_1038_s41467_020_19917_0
crossref_primary_10_1007_s13566_015_0240_5
crossref_primary_10_3389_fonc_2023_1143335
crossref_primary_10_14791_btrt_2013_1_1_2
crossref_primary_10_1016_j_semradonc_2020_11_002
crossref_primary_10_3389_fimmu_2023_1148692
crossref_primary_10_1016_j_imbio_2019_05_011
crossref_primary_10_1158_2326_6066_CIR_15_0156
crossref_primary_10_1002_smll_202206211
crossref_primary_10_1016_j_canlet_2017_04_039
crossref_primary_10_3390_cells12020332
crossref_primary_10_1245_s10434_021_10276_8
crossref_primary_10_1016_j_radonc_2018_12_001
crossref_primary_10_1055_s_0040_1721454
crossref_primary_10_3390_vaccines11071275
crossref_primary_10_1002_advs_202204932
crossref_primary_10_3390_jcm10215124
crossref_primary_10_1038_s41598_018_27718_1
crossref_primary_10_2967_jnumed_118_218917
crossref_primary_10_1007_s00108_020_00816_x
crossref_primary_10_3390_cancers14174213
crossref_primary_10_1038_nrclinonc_2015_120
crossref_primary_10_1080_2162402X_2023_2222560
crossref_primary_10_1002_smll_202101460
crossref_primary_10_1016_j_clcc_2022_03_001
crossref_primary_10_1200_JCO_2017_76_2229
crossref_primary_10_1016_j_it_2018_06_001
crossref_primary_10_1177_1758835918762094
crossref_primary_10_3389_fonc_2023_1225720
crossref_primary_10_2217_fon_2017_0150
crossref_primary_10_1007_s11654_021_00347_3
crossref_primary_10_1038_nrclinonc_2016_211
crossref_primary_10_1155_2019_1483406
crossref_primary_10_1016_j_ijrobp_2021_06_041
crossref_primary_10_1016_j_heliyon_2023_e22092
crossref_primary_10_1007_s10269_015_2543_y
crossref_primary_10_1002_advs_202302141
crossref_primary_10_1016_j_clbc_2021_06_016
crossref_primary_10_1111_ajco_12256
crossref_primary_10_1158_1078_0432_CCR_18_1126
crossref_primary_10_1016_S1470_2045_17_30380_7
crossref_primary_10_1038_s41598_020_78577_8
crossref_primary_10_1093_jnci_djx234
crossref_primary_10_1016_j_canrad_2023_05_002
crossref_primary_10_2217_imt_15_9
crossref_primary_10_3389_fphy_2019_00046
crossref_primary_10_3390_ijms19092653
crossref_primary_10_1016_j_ejcsup_2013_07_040
crossref_primary_10_1038_cgt_2016_56
crossref_primary_10_1039_C9NR05371A
crossref_primary_10_1016_j_semradonc_2019_12_001
crossref_primary_10_1158_2326_6066_CIR_22_0547
crossref_primary_10_3389_fonc_2022_880712
crossref_primary_10_1016_j_ijrobp_2021_05_132
crossref_primary_10_3389_fimmu_2017_00099
crossref_primary_10_1002_pros_24721
crossref_primary_10_1002_adhm_202301083
crossref_primary_10_1186_s40425_019_0520_5
crossref_primary_10_1183_23120541_00189_2019
crossref_primary_10_3389_fonc_2018_00680
crossref_primary_10_1080_02656736_2020_1810333
crossref_primary_10_1016_j_clml_2014_07_010
crossref_primary_10_1200_JCO_2015_61_1509
crossref_primary_10_1002_hed_25476
crossref_primary_10_1126_sciadv_adk1827
crossref_primary_10_1200_CCI_18_00075
crossref_primary_10_1093_neuonc_noaa019
crossref_primary_10_1038_s41598_022_18251_3
crossref_primary_10_1159_000510385
crossref_primary_10_3389_fmolb_2023_1148389
crossref_primary_10_1136_bcr_2020_240806
crossref_primary_10_2217_imt_2017_0002
crossref_primary_10_1016_j_ijrobp_2018_02_175
crossref_primary_10_1038_s41467_022_32645_x
crossref_primary_10_1002_ijc_34801
crossref_primary_10_3389_fonc_2022_778643
crossref_primary_10_1038_s41401_020_0414_6
crossref_primary_10_1007_s00262_016_1843_4
crossref_primary_10_1016_j_immuni_2015_03_009
crossref_primary_10_1038_s41578_019_0108_1
crossref_primary_10_1667_RR13458_1
crossref_primary_10_2217_fon_2021_0483
crossref_primary_10_1186_s40425_018_0317_y
crossref_primary_10_1186_s40814_020_00693_z
crossref_primary_10_3390_cancers12051121
crossref_primary_10_1007_s11060_015_1762_9
crossref_primary_10_1007_s15004_017_5807_4
crossref_primary_10_1016_j_ijrobp_2017_07_031
crossref_primary_10_3390_cancers13225859
crossref_primary_10_1186_s13046_024_02992_2
crossref_primary_10_3390_ijms21134585
crossref_primary_10_1007_s11912_014_0420_2
crossref_primary_10_3389_fphar_2019_00511
crossref_primary_10_3389_fonc_2021_653141
crossref_primary_10_1080_2162402X_2015_1008866
crossref_primary_10_1093_gastro_goz061
crossref_primary_10_1093_pcmedi_pbz004
crossref_primary_10_1016_j_ijrobp_2018_02_156
crossref_primary_10_3389_fonc_2023_1269166
crossref_primary_10_1038_nrclinonc_2016_30
crossref_primary_10_1016_j_semradonc_2021_03_004
crossref_primary_10_1111_imr_12572
crossref_primary_10_3389_fonc_2014_00325
crossref_primary_10_1111_imr_12573
crossref_primary_10_1126_scitranslmed_abb3631
crossref_primary_10_1016_j_adro_2018_08_019
crossref_primary_10_1200_EDBK_238339
crossref_primary_10_3389_fonc_2021_638873
crossref_primary_10_46310_tjim_1076459
crossref_primary_10_1186_s13045_020_00940_z
crossref_primary_10_1259_bjr_20190378
crossref_primary_10_1016_j_ijrobp_2016_02_063
crossref_primary_10_1186_s13256_020_02578_4
crossref_primary_10_1158_0008_5472_CAN_14_3511
crossref_primary_10_3748_wjg_v23_i29_5395
crossref_primary_10_1667_RR3819_1
crossref_primary_10_1158_1078_0432_CCR_16_0049
crossref_primary_10_1186_s40164_018_0120_y
crossref_primary_10_3389_fimmu_2020_582106
crossref_primary_10_1016_j_canrad_2014_06_012
crossref_primary_10_1016_j_ijrobp_2019_01_073
crossref_primary_10_1016_j_breast_2017_12_005
crossref_primary_10_1002_cam4_1880
crossref_primary_10_3390_cancers14184530
crossref_primary_10_1016_j_eclinm_2019_10_013
crossref_primary_10_3390_vaccines6010009
crossref_primary_10_4161_onci_29028
crossref_primary_10_3389_fimmu_2023_1306534
crossref_primary_10_1016_j_ijrobp_2021_09_010
crossref_primary_10_3389_fonc_2020_01668
crossref_primary_10_3390_cancers12082193
crossref_primary_10_1186_s13073_019_0653_7
crossref_primary_10_4161_21624011_2014_955691
crossref_primary_10_1007_s12017_021_08668_w
crossref_primary_10_1007_s10585_018_9926_6
crossref_primary_10_1097_CCO_0000000000000493
crossref_primary_10_1159_000533858
crossref_primary_10_3390_biomedicines6010007
crossref_primary_10_1080_2162402X_2022_2158013
crossref_primary_10_1016_j_ijrobp_2017_12_260
crossref_primary_10_1038_s41573_024_00974_9
crossref_primary_10_1016_j_hoc_2019_09_007
crossref_primary_10_1038_s41598_024_59961_0
crossref_primary_10_1038_s41573_020_0074_8
crossref_primary_10_1259_bjr_20200042
crossref_primary_10_3390_cancers10120515
crossref_primary_10_3390_cancers15215124
crossref_primary_10_1158_1078_0432_CCR_13_3229
crossref_primary_10_1016_j_radonc_2021_06_037
crossref_primary_10_1088_1478_3975_ab1a09
crossref_primary_10_3390_cancers12092429
crossref_primary_10_1016_j_coph_2014_07_004
crossref_primary_10_1186_s13058_017_0870_1
crossref_primary_10_1667_RR13374_1
crossref_primary_10_1007_s00066_017_1179_9
crossref_primary_10_1182_bloodadvances_2018023119
crossref_primary_10_1016_j_ijrobp_2018_04_038
crossref_primary_10_18632_oncotarget_20411
crossref_primary_10_3390_life13010006
crossref_primary_10_1080_15384047_2017_1345389
crossref_primary_10_3389_fimmu_2017_00229
crossref_primary_10_1158_2326_6066_CIR_15_0238
crossref_primary_10_3389_fonc_2021_647272
crossref_primary_10_1038_s41467_018_04703_w
crossref_primary_10_3389_fonc_2019_01381
crossref_primary_10_1016_j_canlet_2023_216108
crossref_primary_10_1097_PPO_0000000000000203
crossref_primary_10_1080_2162402X_2020_1771925
crossref_primary_10_1038_s41598_021_04630_9
crossref_primary_10_3389_fonc_2019_00059
crossref_primary_10_1016_j_neo_2022_100864
crossref_primary_10_3389_fonc_2017_00066
crossref_primary_10_1158_0008_5472_CAN_13_1314
crossref_primary_10_3389_froh_2023_1180869
crossref_primary_10_3349_ymj_2018_59_5_567
crossref_primary_10_3389_fonc_2018_00609
crossref_primary_10_1016_j_ijrobp_2019_12_030
crossref_primary_10_1038_s41419_022_04639_6
crossref_primary_10_3389_fonc_2021_737425
crossref_primary_10_1016_j_yao_2021_02_002
crossref_primary_10_1186_s13014_022_02073_8
crossref_primary_10_1158_1078_0432_CCR_19_2034
crossref_primary_10_1016_j_cclet_2023_109225
crossref_primary_10_3389_fonc_2018_00056
crossref_primary_10_3389_fonc_2021_672677
crossref_primary_10_18528_ijgii230072
crossref_primary_10_3390_cancers13225725
crossref_primary_10_3389_fonc_2020_604387
crossref_primary_10_1093_annonc_mdu450
crossref_primary_10_3389_fonc_2023_1175965
crossref_primary_10_1016_j_cllc_2018_01_001
crossref_primary_10_1016_j_semcancer_2015_02_004
crossref_primary_10_3390_ijms21197378
Cites_doi 10.1186/bcr2160
10.1158/1078-0432.728.11.2
10.1016/j.ijrobp.2003.09.012
10.1056/NEJMoa1112824
10.1146/annurev-immunol-031210-101324
10.1016/S1470-2045(09)70082-8
10.1016/j.smim.2010.03.001
10.1200/JCO.2010.28.9793
ContentType Journal Article
Copyright Elsevier Inc.
2012 Elsevier Inc.
Copyright_xml – notice: Elsevier Inc.
– notice: 2012 Elsevier Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijrobp.2012.06.020
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-355X
EndPage 880
ExternalDocumentID 10_1016_j_ijrobp_2012_06_020
23078897
S0360301612008462
1_s2_0_S0360301612008462
Genre Editorial
Commentary
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA161891
– fundername: NCI NIH HHS
  grantid: P30 CA016087
– fundername: NCRR NIH HHS
  grantid: S10 RR027619
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
1B1
1P~
1RT
1~5
29J
4.4
457
4G.
53G
5RE
5VS
7-5
AAEDT
AAEDW
AALRI
AAQFI
AAQQT
AAQXK
AAWTL
AAXUO
ABEFU
ABJNI
ABLJU
ABNEU
ABOCM
ABUDA
ACGFS
ACIUM
ADBBV
ADMUD
ADPAM
ADVLN
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFRHN
AFTJW
AGRDE
AHHHB
AITUG
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ASPBG
AVWKF
AZFZN
BELOY
DU5
EBS
EFJIC
EJD
F5P
FDB
FEDTE
FGOYB
FIRID
G-2
GBLVA
HED
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
KOM
LX3
M41
MO0
NQ-
O9-
OC~
OO-
R2-
RIG
RNS
ROL
RPZ
SAE
SDG
SEL
SES
SEW
SSZ
UDS
UV1
X7M
XH2
XPP
Z5R
ZGI
~S-
AAIAV
AGZHU
ALXNB
ZA5
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c514t-2db1933eef51df0856b166133f4b24efe68a39d315bc5c2f0745f887d14911063
ISSN 0360-3016
IngestDate Fri Oct 25 21:54:31 EDT 2024
Thu Sep 26 17:08:36 EDT 2024
Sat Sep 28 08:07:43 EDT 2024
Fri Feb 23 02:26:52 EST 2024
Tue Oct 15 22:52:43 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c514t-2db1933eef51df0856b166133f4b24efe68a39d315bc5c2f0745f887d14911063
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
OpenAccessLink http://www.redjournal.org/article/S0360301612008462/pdf
PMID 23078897
PQID 1237085444
PQPubID 23479
PageCount 2
ParticipantIDs proquest_miscellaneous_1237085444
crossref_primary_10_1016_j_ijrobp_2012_06_020
pubmed_primary_23078897
elsevier_sciencedirect_doi_10_1016_j_ijrobp_2012_06_020
elsevier_clinicalkeyesjournals_1_s2_0_S0360301612008462
PublicationCentury 2000
PublicationDate 2012-11-15
PublicationDateYYYYMMDD 2012-11-15
PublicationDate_xml – month: 11
  year: 2012
  text: 2012-11-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle International journal of radiation oncology, biology, physics
PublicationTitleAlternate Int J Radiat Oncol Biol Phys
PublicationYear 2012
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Stone, Peters, Milas (bib6) 1979; 63
Demaria, Kawashima, Yang (bib10) 2005; 11
Brody, Ai, Czerwinski (bib3) 2010; 28
Formenti, Demaria (bib5) 2009; 10
Demaria, Ng, Devitt (bib4) 2004; 58
Vesely, Kershaw, Schreiber (bib8) 2011; 29
Stamell, Wolchok, Gnjatic (bib2) 7 May 2012
Ma, Kepp, Ghiringhelli (bib9) 2010; 22
Formenti, Demaria (bib7) 2008; 10
Postow, Callahan, Barker (bib1) 2012; 366
291749 - J Natl Cancer Inst. 1979 Nov;63(5):1229-35
22560555 - Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):293-5
14967443 - Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):862-70
21219185 - Annu Rev Immunol. 2011;29:235-71
19014406 - Breast Cancer Res. 2008;10(6):215
20403709 - Semin Immunol. 2010 Jun;22(3):113-24
20697067 - J Clin Oncol. 2010 Oct 1;28(28):4324-32
22397654 - N Engl J Med. 2012 Mar 8;366(10):925-31
19573801 - Lancet Oncol. 2009 Jul;10(7):718-26
15701862 - Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):728-34
Postow (10.1016/j.ijrobp.2012.06.020_bib1) 2012; 366
Demaria (10.1016/j.ijrobp.2012.06.020_bib4) 2004; 58
Formenti (10.1016/j.ijrobp.2012.06.020_bib5) 2009; 10
Stamell (10.1016/j.ijrobp.2012.06.020_bib2) 2012
Demaria (10.1016/j.ijrobp.2012.06.020_bib10) 2005; 11
Formenti (10.1016/j.ijrobp.2012.06.020_bib7) 2008; 10
Vesely (10.1016/j.ijrobp.2012.06.020_bib8) 2011; 29
Brody (10.1016/j.ijrobp.2012.06.020_bib3) 2010; 28
Ma (10.1016/j.ijrobp.2012.06.020_bib9) 2010; 22
Stone (10.1016/j.ijrobp.2012.06.020_bib6) 1979; 63
References_xml – volume: 28
  start-page: 4324
  year: 2010
  end-page: 4332
  ident: bib3
  article-title: In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
  publication-title: J Clin Oncol
  contributor:
    fullname: Czerwinski
– volume: 58
  start-page: 862
  year: 2004
  end-page: 870
  ident: bib4
  article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Devitt
– volume: 10
  start-page: 718
  year: 2009
  end-page: 726
  ident: bib5
  article-title: Systemic effects of local radiotherapy
  publication-title: Lancet Oncol
  contributor:
    fullname: Demaria
– volume: 11
  start-page: 728
  year: 2005
  end-page: 734
  ident: bib10
  article-title: Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer
  publication-title: Clin Cancer Res
  contributor:
    fullname: Yang
– volume: 22
  start-page: 113
  year: 2010
  end-page: 124
  ident: bib9
  article-title: Chemotherapy and radiotherapy: cryptic anticancer vaccines
  publication-title: Semin Immunol
  contributor:
    fullname: Ghiringhelli
– year: 7 May 2012
  ident: bib2
  article-title: The abscopal effect associated with a systemic anti-melanoma immune response
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Gnjatic
– volume: 10
  start-page: 215
  year: 2008
  ident: bib7
  article-title: Local control by radiotherapy: is that all there is?
  publication-title: Breast Cancer Res
  contributor:
    fullname: Demaria
– volume: 366
  start-page: 925
  year: 2012
  end-page: 931
  ident: bib1
  article-title: Immunologic correlates of the abscopal effect in a patient with melanoma
  publication-title: N Engl J Med
  contributor:
    fullname: Barker
– volume: 63
  start-page: 1229
  year: 1979
  end-page: 1235
  ident: bib6
  article-title: Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Milas
– volume: 29
  start-page: 235
  year: 2011
  end-page: 271
  ident: bib8
  article-title: Natural innate and adaptive immunity to cancer
  publication-title: Annu Rev Immunol
  contributor:
    fullname: Schreiber
– volume: 10
  start-page: 215
  year: 2008
  ident: 10.1016/j.ijrobp.2012.06.020_bib7
  article-title: Local control by radiotherapy: is that all there is?
  publication-title: Breast Cancer Res
  doi: 10.1186/bcr2160
  contributor:
    fullname: Formenti
– volume: 11
  start-page: 728
  year: 2005
  ident: 10.1016/j.ijrobp.2012.06.020_bib10
  article-title: Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.728.11.2
  contributor:
    fullname: Demaria
– volume: 58
  start-page: 862
  year: 2004
  ident: 10.1016/j.ijrobp.2012.06.020_bib4
  article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/j.ijrobp.2003.09.012
  contributor:
    fullname: Demaria
– volume: 366
  start-page: 925
  year: 2012
  ident: 10.1016/j.ijrobp.2012.06.020_bib1
  article-title: Immunologic correlates of the abscopal effect in a patient with melanoma
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1112824
  contributor:
    fullname: Postow
– volume: 29
  start-page: 235
  year: 2011
  ident: 10.1016/j.ijrobp.2012.06.020_bib8
  article-title: Natural innate and adaptive immunity to cancer
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-031210-101324
  contributor:
    fullname: Vesely
– volume: 10
  start-page: 718
  year: 2009
  ident: 10.1016/j.ijrobp.2012.06.020_bib5
  article-title: Systemic effects of local radiotherapy
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(09)70082-8
  contributor:
    fullname: Formenti
– volume: 22
  start-page: 113
  year: 2010
  ident: 10.1016/j.ijrobp.2012.06.020_bib9
  article-title: Chemotherapy and radiotherapy: cryptic anticancer vaccines
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2010.03.001
  contributor:
    fullname: Ma
– volume: 28
  start-page: 4324
  year: 2010
  ident: 10.1016/j.ijrobp.2012.06.020_bib3
  article-title: In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.28.9793
  contributor:
    fullname: Brody
– volume: 63
  start-page: 1229
  year: 1979
  ident: 10.1016/j.ijrobp.2012.06.020_bib6
  article-title: Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma
  publication-title: J Natl Cancer Inst
  contributor:
    fullname: Stone
– year: 2012
  ident: 10.1016/j.ijrobp.2012.06.020_bib2
  article-title: The abscopal effect associated with a systemic anti-melanoma immune response
  publication-title: Int J Radiat Oncol Biol Phys
  contributor:
    fullname: Stamell
SSID ssj0001174
Score 2.5573778
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 879
SubjectTerms Animals
Cell Death - immunology
Combined Modality Therapy - methods
CTLA-4 Antigen - antagonists & inhibitors
Hematology, Oncology and Palliative Medicine
Humans
Immune System - immunology
Immune Tolerance - immunology
Immunity, Cellular
Immunologic Memory
Immunotherapy - methods
Mice
Neoplasms - immunology
Neoplasms - radiotherapy
Radiation Tolerance - immunology
Radiology
T-Lymphocytes - immunology
Title Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0360301612008462
https://dx.doi.org/10.1016/j.ijrobp.2012.06.020
https://www.ncbi.nlm.nih.gov/pubmed/23078897
https://search.proquest.com/docview/1237085444
Volume 84
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JaxsxFBZtAqWX0nR1N1TorYzxSJrtEghtQmiWQmpT34S2AZtkpozHPfTX52mZBZLQtJexEZ4R1qd5-t7T-_QQ-jRTtIiZSSOj7TajUGmUi1JHhMK7JFVcJIkVCp-dp8cL9m2ZLLsa7kFd0sqp-nOrruR_UIU2wNWqZP8B2f6h0ADfAV-4AsJwvRfGF_ZgAQegl1E5JunyyBsnUfzcbq9cvjk0C5fSuFm1tlSv6rfT10Mm-xAYHB0n0fRd1JXqlS1yELn40EjPzF32kQupri5_r8QQhP1qrsAtFz4KXelGjOMNMbHCO6-4nBpvI_OsiICmLMdG1Nd5C5OFjSxi7mvFdIurL9t0w277EMJ6ulo3tbTHiNoQbTqdkdmwTnV78-ff-dHi9JTPD5fzh2iXgIUB07Z7cHLx86RfhGPwtDqlpEvnu_nku5jIXZ6GYxzzp-hJcBXwgcd9Dz0w1TP06CwkQzxH-z38OMCP2xoH-G0TdvBjCz8WFXxiCz8O8L9Ai6PD-ZfjKJTDiBSw2jYiWgLbpsaUSaxLoMqpjIFdUVoySZgpTZoLWmgaJ1IlipRADpMS1hANTjCQvJS-RDtVXZnXCBcks-feZ7lmhjEtpDaJoUzl4L6mhdITFHVDw3_5U094lw645n4ouR1KbrMiyWyCsm78eKfohTXIbMJ83fCYb-DH_AcQJuuEA6-2lRxSMr4zcD7P5ThMjb_0-bEDioNJtPtcojL1FvoiNIPhYYxN0CuPYP8vrO4hz4vszT3ufoseDy_AO7TTNlvzHihoKz-E6XYNIf-Ktw
link.rule.ids 315,783,787,27936,27937
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Radiation+therapy+to+convert+the+tumor+into+an+in+situ+vaccine&rft.jtitle=International+journal+of+radiation+oncology%2C+biology%2C+physics&rft.au=menti%2C+Silvia+C&rft.au=Demaria%2C+Sandra&rft.date=2012-11-15&rft.eissn=1879-355X&rft.volume=84&rft.issue=4&rft.spage=879&rft.epage=880&rft_id=info:doi/10.1016%2Fj.ijrobp.2012.06.020&rft.externalDBID=NO_FULL_TEXT
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03603016%2FS0360301612X00026%2Fcov150h.gif